Anju provides end-to-end software solutions that help customers manage mission-critical pharma processes and turn data into actionable insights.
Anju Software is a leading provider of comprehensive software solutions to the life sciences industry. Anju provides an integrated platform spanning clinical operations and medical affairs. Anju has combined deep industry and software domain expertise to build a next generation platform for the life sciences sector that can scale to provide solutions that meet customers’ needs from “molecule to retirement”.
Anju provides end-to-end software solutions that help customers manage mission-critical pharma processes and turn data into actionable insights. Anju’s philosophy is to support and guide clients over the long term in meeting their evolving software needs. Anju’s mission is to complement its strong product offering with exceptional customer support and delivering true quantifiable value.
Anju solutions are used by large and small pharmaceutical companies, clinical research organizations (CRO), full service agencies and medical device companies. Data flow between our systems, seamless communication with third party systems and AI-based data mining solutions provide a unique way for our customers to leverage critical information throughout their ecosystem.
Anju is a portfolio company of Providence Strategic Growth Fund, a unit of Providence Equity Partners. Providence is a premier, global asset management firm with $57 billion in assets under management across complementary private equity and credit businesses. Providence pioneered a sector focused approach to private equity investing with the vision that a dedicated team of industry experts could build exceptional companies of enduring value.